Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001985314 | SCV002222152 | uncertain significance | Combined oxidative phosphorylation defect type 27 | 2021-10-20 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with CARS2-related conditions. This variant is present in population databases (rs751712957, ExAC 0.01%). This sequence change replaces cysteine with glycine at codon 296 of the CARS2 protein (p.Cys296Gly). The cysteine residue is moderately conserved and there is a large physicochemical difference between cysteine and glycine. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |